The treatment of early stage prostate cancer is shrouded with controversy, as it is well recognized that many men are overtreated for malignancy that might never become clinically significant.
Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback